Minimal symptom expression achievement over time in generalized myasthenia gravis.
Akiyuki UzawaYukiko OzawaManato YasudaYosuke OnishiHiroyuki AkamineSatoshi KuwabaraPublished in: Acta neurologica Belgica (2023)
From the early phases of immunotherapy, MSE is a good marker of therapeutic goal in patients with generalized MG.